AAPL $341.36 -0.37% ▼ ACN $232.11 +1.77% ▲ ADBE $244.60 +0.49% ▲ ADEA $20.99 +4.07% ▲ ADIG $15.96 +3.10% ▲ ADP $286.24 -0.92% ▼ ADSK $237.81 -0.87% ▼ AEHR $64.60 +6.59% ▲ AEVA $10.14 +0.90% ▲ AGYS $112.83 +2.66% ▲ AI $11.44 +1.56% ▲ AIP $19.33 +2.98% ▲ ALAB $294.14 +3.57% ▲ ALKT $13.78 +0.44% ▲ ALNT $96.00 +3.63% ▲ AMBA $63.33 +2.91% ▲ AMBQ $50.10 +0.44% ▲ AMD $548.12 +3.99% ▲ AMPL $15.10 +2.37% ▲ AMZN $262.45 +5.41% ▲ ANET $184.30 +4.55% ▲ AOSL $22.78 +4.74% ▲ APLD $19.90 +10.19% ▲ APP $266.91 +0.36% ▲ APPN $42.31 +2.77% ▲ APPS $9.30 -2.31% ▼ ARM $232.54 +2.44% ▲ ARRY $3.27 -4.39% ▼ ARW $217.68 +1.40% ▲ ASML $1,673.16 +2.00% ▲ AAPL $341.36 -0.37% ▼ ACN $232.11 +1.77% ▲ ADBE $244.60 +0.49% ▲ ADEA $20.99 +4.07% ▲ ADIG $15.96 +3.10% ▲ ADP $286.24 -0.92% ▼ ADSK $237.81 -0.87% ▼ AEHR $64.60 +6.59% ▲ AEVA $10.14 +0.90% ▲ AGYS $112.83 +2.66% ▲ AI $11.44 +1.56% ▲ AIP $19.33 +2.98% ▲ ALAB $294.14 +3.57% ▲ ALKT $13.78 +0.44% ▲ ALNT $96.00 +3.63% ▲ AMBA $63.33 +2.91% ▲ AMBQ $50.10 +0.44% ▲ AMD $548.12 +3.99% ▲ AMPL $15.10 +2.37% ▲ AMZN $262.45 +5.41% ▲ ANET $184.30 +4.55% ▲ AOSL $22.78 +4.74% ▲ APLD $19.90 +10.19% ▲ APP $266.91 +0.36% ▲ APPN $42.31 +2.77% ▲ APPS $9.30 -2.31% ▼ ARM $232.54 +2.44% ▲ ARRY $3.27 -4.39% ▼ ARW $217.68 +1.40% ▲ ASML $1,673.16 +2.00% ▲
Tech Presswire
Other NMS

Regeneron Pharmaceuticals, Inc. (REGN)

Other · Healthcare · Biotechnology

REGN
782.00-8.75 -1.11%Past year
Loading chart…
Loading financials…

Company snapshot

Ticker
REGN
Exchange
NMS
Sector
Healthcare
Industry
Biotechnology
Market cap
$80.65B
Employees
15,410
Currency
USD
Website
https://www.regeneron.com

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of…

Latest coverage

Related Other stocks

S&P Global Inc.SPGI
Nasdaq, Inc.NDAQ
M&T Bank CorporationMTB
Comtech Telecommunications Corp.CMTL

Quotes & data — follow Regeneron Pharmaceuticals, Inc. (REGN) across major market-data sources

Yahoo Finance ↗ Google Finance ↗ MarketWatch ↗ StockTwits ↗ TradingView ↗ Company website ↗